AI assistant
Sending…
Bure Equity — M&A Activity 2011
Jul 4, 2011
2899_rns_2011-07-04_afa120cb-c907-45f0-ab41-734b21f9b4ac.pdf
M&A Activity
Open in viewerOpens in your device viewer
PRESSMEDDELANDE Stockholm, den 4 juli 2011
PORTFÖLJBOLAGET CMA MICRODIALYSIS OMSTRUKTURERAR VERKSAMHETEN
Bure Equitys portföljbolag CMA Microdialysis avyttrar sin prekliniska verksamhet, säljer dotterbolaget Dilab och byter namn på den kvarvarande verksamheten till Dipylon Medical AB.
För mer information se bifogade pressmeddelanden samt Dipylon Medicals hemsida:
www.dipylonmedical.com
Stockholm den 4 juli 2011
Bure Equity AB (publ)
Kontaktperson på Bure:
Patrik Tigerschiöld, VD Tel: 08-614 00 20
Bure Equity AB (publ)
More from Bure Equity
Interim / Quarterly Report
2026
May 18
Interim / Quarterly Report
2026
May 18
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
AGM Information
2026
May 12
Annual Report
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Share Issue/Capital Change
2025
Nov 28
Share Issue/Capital Change
2025
Nov 28
Share Issue/Capital Change
2025
Nov 11